Shares of Novacyt (LON: NCYT) have been inching higher slowly since bouncing off the 200p support level in mid-July to form a rising wedge as shown in the chart below.
The company’s stock price has not made a significant move in either direction despite a slew of positive developments announced by the company in recent weeks.
Some of the positive milestones achieved by the biotechnology company, which is focused on developing diagnostic products, include the signing of a distribution agreement in the US giving it access to the lucrative American market.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The company has also witnessed rising demand for its COVID-19 test, which recorded sales worth $22.5 million in June, according to a trading update.
The firm is also set to launch new 2-gene tests next month in addition to hosting its Annual General Meeting on 25th September.
Given the recent positive developments, it is highly likely that Novacyt shares shall break to the upside sooner rather than later.
Novacyt share price
The stock is likely to rally higher once it clears the 316p-343p resistance zone highlighted above.
